Scientific Literature Search

Open access

A systematic review of biomarkers for disease progression in Parkinson's disease.

McGhee DJ, Royle PL, Thompson PA, Wright DE, Zajicek JP, Counsell CE.

BMC Neurol · 2013-04-12

DOI: 10.1186/1471-2377-13-35PMID: 23587062

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers.

DeKosky ST, Blennow K, Ikonomovic MD, Gandy S.

Nat Rev Neurol · 2013-04-01

DOI: 10.1038/nrneurol.2013.36PMID: 23558985

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex.

Nakayama Y, Morimoto S, Yoneda M, Kuzuhara S, Kokubo Y.

J Neurodegener Dis · 2013-03-27

DOI: 10.1155/2013/679089PMID: 26316995

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathology.

Maarouf CL, Beach TG, Adler CH, Malek-Ahmadi M, Kokjohn TA, Dugger BN, Walker DG, Shill HA, Jacobson SA, Sabbagh MN, Roher AE, Arizona Parkinson’s Disease Consortium.

Biomark Insights · 2013-03-12

DOI: 10.4137/bmi.s11422PMID: 23533154

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.

Ulla M, Bonny JM, Ouchchane L, Rieu I, Claise B, Durif F.

PLoS One · 2013-03-01

DOI: 10.1371/journal.pone.0057904PMID: 23469252

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

NINDS boosts research for biomarkers in Parkinson's disease.

Check source for author details

Lancet Neurol · 2013-03-01

DOI: 10.1016/s1474-4422(13)70029-2PMID: 23415560

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Launch of a US$5 million Parkinson’s Disease Biomarkers Program in the USA.

King G.

Bioanalysis · 2013-03-01

PMID: 23544251

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease?

Duncan GW, Firbank MJ, O'Brien JT, Burn DJ.

Mov Disord · 2013-02-28

DOI: 10.1002/mds.25352PMID: 23450518

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease?

Yarnall AJ, Rochester L, Baker MR, David R, Khoo TK, Duncan GW, Galna B, Burn DJ.

Mov Disord · 2013-02-28

DOI: 10.1002/mds.25360PMID: 23450646

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis.

Tanaka H, Shimazawa M, Takata M, Kaneko H, Tsuruma K, Ikeda T, Warita H, Aoki M, Yamada M, Takahashi H, Hozumi I, Minatsu H, Inuzuka T, Hara H.

J Neurol · 2013-02-23

DOI: 10.1007/s00415-013-6877-3PMID: 23436019

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Cerebrospinal fluid biomarkers in Parkinson disease.

Parnetti L, Castrioto A, Chiasserini D, Persichetti E, Tambasco N, El-Agnaf O, Calabresi P.

Nat Rev Neurol · 2013-02-19

DOI: 10.1038/nrneurol.2013.10PMID: 23419373

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Brain injury biomarkers are not dependent on β-amyloid in normal elderly.

Knopman DS, Jack CR, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC.

Ann Neurol · 2013-02-19

DOI: 10.1002/ana.23816PMID: 23424032

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

3.162 articles found

A systematic review of biomarkers for disease progression in Parkinson's disease.

Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers.

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex.

Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathology.

Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.

NINDS boosts research for biomarkers in Parkinson's disease.

Launch of a US$5 million Parkinson’s Disease Biomarkers Program in the USA.

Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease?

Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease?

ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis.

Cerebrospinal fluid biomarkers in Parkinson disease.

Brain injury biomarkers are not dependent on β-amyloid in normal elderly.

Filters